Takeda Pharmaceutical Company Limited (TKPYY)


Other OTC - Other OTC Delayed Price. Currency in USD
22.34-0.18 (-0.80%)
At close: 3:58 PM EDT
People also watch:
ALPMYESALYDSNKYTKOMYSVNDY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open22.40
Prev Close22.52
Bid0.00 x
Ask0.00 x
Day's Range22.22 - 22.63
52wk Range20.32 - 25.72
1y Target EstN/A
Market Cap34.93B
P/E Ratio (ttm)22.70
Beta0.34
Volume40,775
Avg Vol (3m)59,651
Dividend & Yield0.87 (3.84%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETF’s with exposure to Takeda Pharmaceutical Co., Ltd. : August 24, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Takeda Pharmaceutical Co., Ltd. Here are 5 ETF’s with the largest exposure to TKPYY-US. Comparing the performance and risk of Takeda Pharmaceutical Co., Ltd. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Reuters9 days ago

    Hitachi, Carlyle, Permira among bidders for $1 bln Takeda unit-sources

    Hitachi Ltd and buyout firms Carlyle Group and Permira are among suitors to buy Takeda Pharmaceutical Co's chemicals unit, people with knowledge of the matter said, in a deal that could total around $1 billion. Takeda Pharmaceutical, Japan's largest drugmaker by market value, has put its 70 percent stake in unlisted Wako Pure Chemicals Industries Ltd on the block to streamline operations. Hitachi placed its bid through unit Hitachi Chemical Co , one of the sources said on Wednesday.

  • Takeda Pharmaceutical Co., Ltd. :TKPYY-US: Earnings Analysis: Q1, 2017 By the Numbers : August 5, 2016
    Capital Cube21 days ago

    Takeda Pharmaceutical Co., Ltd. :TKPYY-US: Earnings Analysis: Q1, 2017 By the Numbers : August 5, 2016

    Categories: Yahoo Finance Click here to see latest analysis Takeda Pharmaceutical Co., Ltd. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Takeda Pharmaceutical Co., Ltd. – Pfizer Inc., Johnson & Johnson, Amgen Inc., GlaxoSmithKline plc Sponsored ADR, Novartis AG Sponsored ADR, Merck & Co., Inc., Seattle ... Read more (Read more...)